Health and Healthcare
FDA: Thin Blood, Sour Stomach (AZN)(BMY)(SNY)
Published:
Last Updated:
The FDA is routinely criticized for being a poor steward of drug research and pharmaceutical side effects. The agency proved once again why much of the criticism is justified.
The FDA today said that two drugs, each of which has been on the market for many years, react badly when taken together. It is a wonder it took so long to figure this out since each of the drugs is very widely used.
Prilosec, an antacid marketed by AstraZeneca (NYSE:AZN), hurts the effectiveness of Plavix which is the world’s most prescribed blood thinner, Plavix is marketed by Sanofi-Aventis (NYSE:SNY) and Bristol-Myers (NYSE:BMY).
Plavix is essential to the treat heart attack victims, patients with vascular stents, and also helps prevent blood clots in the brain. Any drop in its effectiveness is likely to cause real danger to many patients using Plavix.
The FDA is slow to market with news, once again.
Douglas A. McIntyre
Take This Retirement Quiz To Get Matched With An Advisor Now (Sponsored)
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
